Article
Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.
The pharmacogenomics journal - 1 Nov 2016
Krajinovic M, Elbared J, Drouin S, Bertout L, Rezgui A, Ansari M, Raboisson M-J, Lipshultz S E, Silverman L B, Sallan S E, Neuberg D S, Kutok J L, Laverdière C, Sinnett D, Andelfinger G
Abstract excerpt
Anthracyclines are efficient chemotherapy agents. However, their use is limited by anthracycline-induced cardiotoxicity (CT). We investigated the influence of polymorphisms in doxorubicin metabolic and functional pathways on late-onset CT as estimated by echocardiography in 251 childhood acute lymphoblastic leukemia (cALL) patients. Association analyses revealed a modulating effect of two variants: A-1629 T in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
